<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127845">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02034175</url>
  </required_header>
  <id_info>
    <org_study_id>SomnaPatch-001</org_study_id>
    <nct_id>NCT02034175</nct_id>
  </id_info>
  <brief_title>Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing</brief_title>
  <official_title>Comparison of the Somnarus Sleep Apnea Diagnostic Technology SomnaPatch With Polysomnography in Sleep Disordered Breathing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Somnarus Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Somnarus Inc</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for
      diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology
      in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes
      respiration (CSR).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Crossover, Time Perspective: Prospective</study_design>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Central Sleep Apnea</condition>
  <condition>Mixed Sleep Apnea</condition>
  <condition>Cheyne-Stokes Respiration</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patient who have been diagnosed with sleep disordered breathing (apnea or Cheyne-Stokes
        respiration)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to understand and sign the informed consent

          -  Able to comply with visits and follow ups included in this protocol

          -  Ages 20-85 years

        Exclusion Criteria:

          -  An unstable medical condition, acute or chronic, that in the opinion of the
             investigator puts the subject at health risks related this trial or interferes with
             the clinical trial and data collection.

          -  Skin rash on the nose or on the maxillary area.

          -  A history of skin allergy to medical tape, and hypoallergenic tapes.

          -  A history of skin cancer on the nose or on the maxillary area.

          -  A history of the base of skull fractures, facial fractures
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria Merchant, PhD</last_name>
    <phone>408-761-0884</phone>
    <email>somnarus@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peninsula Sleep Center</name>
      <address>
        <city>Burlingame</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliann Nealon, MD</last_name>
      <phone>650-636-9396</phone>
    </contact>
    <investigator>
      <last_name>Mehran Farid-Moayer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 9, 2014</lastchanged_date>
  <firstreceived_date>January 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>apnea</keyword>
  <keyword>hypopnea</keyword>
  <keyword>polysomnography</keyword>
  <keyword>respiratory</keyword>
  <keyword>cheyne</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Cheyne-Stokes Respiration</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
